How to prevent ROP in preterm infants in Indonesia?

Johanes Edy Siswanto1,2, Peter H Dijk3, Arend F Bos3

  • 1Neonatology Working Group, Department of Pediatrics Harapan Kita Women and Children Hospital Jakarta Indonesia.

Health Science Reports
|January 25, 2021
PubMed

Insights

Preventing retinopathy of prematurity (ROP) in preterm infants requires strict oxygen regulation and timely screening. Implementing standard practices like "STOP - R1O2P3" can reduce ROP incidence in low-middle income countries.

Area of Science:

  • Neonatology
  • Ophthalmology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a severe eye disease affecting preterm infants, disproportionately impacting Low-Middle Income Countries (LMIC).
  • Key risk factors include extreme prematurity, oxygen use, infections, respiratory issues, poor nutrition, and blood transfusions.

Purpose of the Study:

  • To provide an overview of ROP prevention strategies for LMIC.
  • To establish guidelines for ROP screening and treatment in these regions.

Main Methods:

  • Literature review and data analysis from Indonesian studies.
  • Development of evidence-based guidelines for ROP prevention, screening, and treatment.

Main Results:

  • Prevention begins prenatally with managing preterm labor and administering corticosteroids. Newborn resuscitation should use room air or limited oxygen (30% for <29-32 weeks).
  • Continuous positive airway pressure (CPAP) and minimally invasive surfactant administration are recommended. Strict oxygen monitoring (91-95% saturation) and infection prevention are crucial.
  • Early nutrition (preferably mother's milk) and minimizing blood draws for transfusions are advised.

Conclusions:

  • Optimal care in specialized facilities is essential for preterm infants. Strict oxygen regulation and mandatory ROP screening for infants born <34 weeks or receiving prolonged oxygen are necessary.
  • Immediate treatment for ROP progression is required. A standardized approach, such as the "STOP - R1O2P3" acronym, can improve ROP prevention and management in LMIC neonatal intensive care units.
Abstract

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.